Prostate News and Research

RSS

Myriad’s myRisk Hereditary Cancer test finds inherited gene mutations in more than 12% of prostate cancer patients

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that results from a large 1,162 patient study of the Myriad myRisk Hereditary Cancer test will be featured during the poster presentation at the 2018 Genitourinary Cancer Symposium in San Francisco, Calif.

8 Feb 2018

New tool to monitor patterns and trends of cancer burden across Europe

On the occasion of the World Cancer Day, the European Commission's Joint Research Centre launched the European Cancer Information System (ECIS), which makes it possible to explore geographical patterns and temporal trends of cancer incidence, mortality, and survival from data submitted by some 150 European population-based cancer registries.

6 Feb 2018

German researchers find way to accurately differentiate prostate cancer from benign tissue

Using nuclear medicine, German researchers have found a way to accurately differentiate cancerous tissue from healthy tissue in prostate cancer patients. The research is highlighted in the February issue of The Journal of Nuclear Medicine.

6 Feb 2018

Australian researchers given a helping hand for stroke research

Australian researchers have been given a helping hand to build projects with the potential to impact future treatment and care for stroke survivors.

6 Feb 2018

Study shows MRI as ideal choice for clarifying ambiguous mammography results

A study of around 300 volunteers, conducted in Austria by MedUni Vienna in collaboration with Diagnostic Graz, convincingly shows that Magnetic Resonance Imaging is the best choice for clarifying ambiguous mammography results.

5 Feb 2018

Tumor activity found in male rats exposed to radiofrequency radiation

High exposure to radiofrequency radiation in rodents resulted in tumors in tissues surrounding nerves in the hearts of male rats, but not female rats or any mice, according to draft studies from the National Toxicology Program.

2 Feb 2018

Exploring the Future of Breast Cancer Risk Assessment

An interview with Dr Gareth Evans about the future of breast cancer screening and the implementation of single nucleotide polymorphism (SNP) profiling.

1 Feb 2018

Research reveals why patients with diabetes have poorer prognosis for prostate cancer

Men with type 2 diabetes are less likely to develop prostate cancer than patients without diabetes. However, the mortality rate is higher.

31 Jan 2018

Computational approach can help identify chemoresistant potential targets in cancer stem cells

In cancer, one of the most important features is the methylation of deoxycytosine to form 5-methylcytosine (5mC). DNA methylation is a process by which methyl groups (structural units of organic compounds consisting of three hydrogen atoms bonded to a carbon atom) are added to the DNA molecule.

30 Jan 2018

As doctors drop opposition, aid-in-dying advocates target next battleground states

When the end draws near, Dr. Roger Kligler, a retired physician with incurable, metastatic prostate cancer, wants the option to use a lethal prescription to die peacefully in his sleep.

27 Jan 2018

Obese men may have elevated risk of biochemical recurrence after radical prostatectomy

Among men with prostate cancer who underwent radical prostatectomy (RP), those who were obese had a higher risk of biochemical recurrence, according to data presented at the American Association for Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27-30.

27 Jan 2018

New gel offers protection for organs at risk during prostate cancer treatment

Radiation therapy is a popular and effective treatment for many men with prostate cancer, and now a temporary gel offers greater protection for organs at risk during treatments.

23 Jan 2018

Study provides more evidence for link between increased cancer risk and advanced gum disease

Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by researchers at the Johns Hopkins Bloomberg School of Public Health, Johns Hopkins Kimmel Cancer Center and Tufts University School of Medicine and Cancer Center.

19 Jan 2018

Researchers find new way to halt growth of breast cancer cells

An international team of researchers led from Karolinska Institutet and Science for Life Laboratory in Sweden have found a new way of halting the growth of breast cancer cells.

18 Jan 2018

Novel gene expression analysis technique can accurately and quickly measure RNA

A University of Illinois and Mayo collaboration has demonstrated a novel gene expression analysis technique that can accurately measure levels of RNA quickly and directly from a cancerous tissue sample while preserving the spatial information across the tissue --something that conventional methods cannot do.

18 Jan 2018

Research: Men who lack HSD17B4 gene may be more susceptible to treatment-resistant prostate cancer

Cleveland Clinic researchers have confirmed for the first time a mechanistic link between the gene HSD17B4 and deadly, treatment-resistant prostate cancer.

17 Jan 2018

Research sheds new light on genetic, environmental factors that promote prostate cancer metastasis

Prostate tumors tend to be what scientists call "indolent" - so slow-growing and self-contained that many affected men die with prostate cancer, not of it. But for the percentage of men whose prostate tumors metastasize, the disease is invariably fatal.

15 Jan 2018

Cycling does not negatively impact sexual and urinary health finds study

A latest study has found that long hours of cycling do not negatively impact sexual and urinary health in men unlike popular belief. The researchers find that the benefits that cycling has on the cardiovascular system of individuals far outweighs any perceived potential risks. The study from the Department of Urology, University of California-San Francisco was published in the latest issue of the Journal of Urology.

15 Jan 2018

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.

12 Jan 2018

Prostate cancer’s gene-determined ‘immune landscape’ dictates tumor progression

The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of patients, suggesting that as-yet unidentified variations among tumors result in distinct paths of disease progression and response to therapy.

12 Jan 2018

Prostate News and Research

Myriad’s myRisk Hereditary Cancer test finds inherited gene mutations in more than 12% of prostate cancer patients

New tool to monitor patterns and trends of cancer burden across Europe

German researchers find way to accurately differentiate prostate cancer from benign tissue

Australian researchers given a helping hand for stroke research

Study shows MRI as ideal choice for clarifying ambiguous mammography results

Tumor activity found in male rats exposed to radiofrequency radiation

Exploring the Future of Breast Cancer Risk Assessment

Research reveals why patients with diabetes have poorer prognosis for prostate cancer

Computational approach can help identify chemoresistant potential targets in cancer stem cells

As doctors drop opposition, aid-in-dying advocates target next battleground states

Obese men may have elevated risk of biochemical recurrence after radical prostatectomy

New gel offers protection for organs at risk during prostate cancer treatment

Study provides more evidence for link between increased cancer risk and advanced gum disease

Researchers find new way to halt growth of breast cancer cells

Novel gene expression analysis technique can accurately and quickly measure RNA

Research: Men who lack HSD17B4 gene may be more susceptible to treatment-resistant prostate cancer

Research sheds new light on genetic, environmental factors that promote prostate cancer metastasis

Cycling does not negatively impact sexual and urinary health finds study

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

Prostate cancer’s gene-determined ‘immune landscape’ dictates tumor progression

What to know about prostate cancer eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News